Kolon Life Science Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Kolon Life Science Inc cash flow conversion efficiency. Based on the latest financial reports, Kolon Life Science Inc (102940) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.58 Billion ≈ $1.75 Million USD) by net assets (₩346.41 Billion ≈ $234.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kolon Life Science Inc (2014–2024)

Cash flow conversion efficiency of Kolon Life Science Inc from 2014 to 2024. This chart illustrates how Kolon Life Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 102940 share price today for real-time trading data and today's change.

Kolon Life Science Inc Cash Flow Conversion Ratio Explained

Kolon Life Science Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kolon Life Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kolon Life Science Inc ranked by their cash flow conversion efficiency. Also see Kolon Life Science Inc market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dongwha Pharm.Co.Ltd KO:000020	0.044x
KEYEAST.Co.Ltd KQ:054780	-0.060x
Patriot National Bancorp Inc NASDAQ:PNBK	-0.063x
Nicola Mining Inc. American Depositary Shares NASDAQ:NICM	-3.612x
DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen XETRA:DAM	-0.026x
Logistic Properties of the Americas NYSE MKT:LPA	0.009x
Kewaunee Scientific Corporation NASDAQ:KEQU	0.026x
Samick Thk KO:004380	0.064x

Annual Cash Flow Conversion Efficiency for Kolon Life Science Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Kolon Life Science Inc from 2014 to 2024. Review how much free cash does Kolon Life Science Inc generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩149.34 Billion ≈ $101.20 Million	₩-14.08 Billion ≈ $-9.55 Million	-0.094x	+47.78%
2023-12-31	₩137.67 Billion ≈ $93.30 Million	₩-24.87 Billion ≈ $-16.85 Million	-0.181x	-45.27%
2022-12-31	₩167.72 Billion ≈ $113.66 Million	₩-20.85 Billion ≈ $-14.13 Million	-0.124x	+23.64%
2021-12-31	₩99.41 Billion ≈ $67.37 Million	₩-16.19 Billion ≈ $-10.97 Million	-0.163x	-29.16%
2020-12-31	₩57.96 Billion ≈ $39.28 Million	₩-7.31 Billion ≈ $-4.95 Million	-0.126x	+36.89%
2019-12-31	₩101.02 Billion ≈ $68.46 Million	₩-20.18 Billion ≈ $-13.68 Million	-0.200x	-555.43%
2018-12-31	₩446.15 Billion ≈ $302.35 Million	₩-13.60 Billion ≈ $-9.22 Million	-0.030x	-100.45%
2017-12-31	₩545.41 Billion ≈ $369.62 Million	₩-8.29 Billion ≈ $-5.62 Million	-0.015x	-114.05%
2016-12-31	₩259.79 Billion ≈ $176.05 Million	₩28.11 Billion ≈ $19.05 Million	0.108x	-29.56%
2015-12-31	₩135.44 Billion ≈ $91.79 Million	₩20.81 Billion ≈ $14.10 Million	0.154x	+72.96%
2014-12-31	₩136.17 Billion ≈ $92.28 Million	₩12.10 Billion ≈ $8.20 Million	0.089x	--

About Kolon Life Science Inc

KQ:102940 Korea Pharmaceuticals

Market Cap

$98.03 Million

₩144.66 Billion KRW

Market Cap Rank

#19074 Global

#915 in Korea

Share Price

₩12680.00

Change (1 day)

-1.32%

52-Week Range

₩12380.00 - ₩70800.00

All Time High

₩163572.85